Stay updated on Pembrolizumab for Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic TNBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed older notices including Revision: v3.4.1 and the government funding status banner.SummaryDifference0.4%

- Check20 days agoChange DetectedA government funding-status notice is now displayed on the page, and the page revision updated from v3.4.0 to v3.4.1, replacing the previous revision.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary visibility was added to the page, and a 'Last Update Submitted that Met QC Criteria' label is now displayed. The 'No FEAR Act Data' label is present and the revision version has been updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed; this appears to be a small platform update with no changes to the study details.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision note 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link as well as the previous 'Revision: v3.3.2' were removed.SummaryDifference0.1%

- Check91 days agoChange DetectedPublications section wording updated to reflect automatic PubMed publications and a new Revision: v3.3.2 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.